Zyprexa

Those who live with schizophrenia and bipolar disorder struggle to keep jobs, maintain relationships, and just live basically "normal" lives. Their families ache for them and want to find some way to help. Doctors, too, wish for a means to end their patients' sufferings. When Zyprexa entered into this scene, it seemed the perfect answer.

Touted as the "best" atypical anti-psychotic drug on the market by maker Eli Lilly and some physicians, Zyprexa began entering the bloodstreams of persons around the world. And soon it entered the mainstream of conversation, too, but not in the positive way its manufacturers would have enjoyed.

Soon after its appearance on the market, many Zyprexa users began realizing that the drug was interfering with their blood sugar levels. For some, that meant a trip to the doctor resulted in a temporary diagnosis of hyperglycemia; for others, the result was a more permanent diagnosis of diabetes. The Zyprexa users who had been led to believe their drug was a salvation were shocked to learn that its side effects were wreaking havoc on their internal systems.

The question on many people's minds at this point was whether or not Zyprexa manufacturer Eli Lilly misled the public about its anti-psychotic drug. For those who felt they had been cheated, lawsuits were pursued. The result was a 2005 almost $700 million settlement between Eli Lilly and angered Zyprexa users who had developed complications from the medication. Though Eli Lilly did not admit to defrauding the public in its press release regarding the settlement, the amount of settlement caused many to begin questioning the effectiveness and safety of Zyprexa.

Eli Lilly might have you believe they have been wronged or victimized, but the true victims in this case have been the Zyprexa users who are now faced with a difficult decision: continue using the drug or stop? Consequently, they have been stuck in a sort of limbo, unsure about their futures with (or without) Zyprexa. For their loved ones, it's just as agonizing as they sit by and watch.

Our firm intends to continue the fight against Zyprexa and its misleading claims. We believe that Eli Lilly may have realized it was a defective drug before sending it to the market (especially after the $700 million settlement mentioned above). Therefore, we'd like to hear from you. Contact our Zyprexa lawyers today.

Comment on this Topic
Your Name:
Your E-mail:
Comments:
	.
	Please enter the security code (characters in this image) into the field below for security purposes
Security Code:

Zyprexa In The News

June 2005 was a red-letter month for Zyprexa patients who had filed claims against the drug's manufacturer, Eli Lilly.

Alleging that the anti-psychotic medication had put them at risk for developing diabetes and hyperglycemia, the plaintiffs demanded compensation for their unexpected Zyprexa side effects.

Their compensation was huge and probably bigger than they expected.

Deciding to settle rather than continue the case, Eli Lilly agreed to pay almost $700 million to those in the Zyprexa lawsuit. Now, individuals who had been adversely affected by the drug touted as the "best" (by many doctors) at controlling schizophrenia and bipolar disorder, would get restitution.

But the case goes far beyond just dollars. The Zyprexa settlement hit the media spotlight in a big way and encouraged people everywhere to begin to question the hidden "costs" behind taking FDA approved medications. They were finally able to see that, sometimes, in the rush to get a product like Zyprexa to market, hoops are jumped through. In this case, those hoops wound up costing Eli Lilly millions... including their reputation.

Of course, Eli Lilly put a good spin on their Zyprexa settlement, claiming in a statement that "We took this difficult step because we believe it is in the best interest of the company, the patients who depend on this medication, and their doctors." (as reported by Fox News, 2005) But behind those happy-sounding words, the Eli Lilly powers-that-be were shaking in their boots.

The main reason for their concerns? Wall Street trading. As happens with most negative media attention, the Zyprexa case caused Eli Lilly's stock to become less than stable. Suddenly, the Eli Lilly executives at the top of the pharmaceutical food chain were scrambling as they tried to protect Zyprexa's reputation. After all, this was the drug that brought in nearly a third of their annual income.

In the end, the furor over Zyprexa died down... somewhat. Media attention turned away from Eli Lilly, and the company had the opportunity to regroup.

But we want to rock the boat again.

We intend to file a lawsuit against Eli Lilly on behalf of Zyprexa users who were misled by the pharmaceutical company. And if you're one of those unlucky Zyprexa users, we want to hear from you. Call us today and together we'll show Eli Lilly and other similar organizations that we won't stand by and allow Zyprexa to harm anyone else. Our Zyprexa lawyers are here for you!